Adjusted net earnings were $13.4 million and Adjusted earnings per share (“Adjusted EPS”) was $0.20 in Q2 2026, compared to $14.4 million and $0.23, respectively, in Q2 2025. Dexterra declared a dividend for Q3 2026 of $0.10 per share for shareholders of record at September 30, 2026, to be paid on October 15, 2026. Article content (1) Please refer to the “Non-GAAP measures” section for the definition of Adjusted EBITDA, Adjusted EBITDA as a percentage of revenue, Adjusted net earnings, Adjusted earnings per share, Free Cash Flow, and to the “Reconciliation of non-GAAP measures” section for the related calculations. Adjusted EBITDA margin for the three months ended June 30, 2026 was 10.1% compared to 10.0% in Q2 2025. Adjusted EBITDA for the three months ended June 30, 2026 was $17.2 million, an increase of 4.1% over Q2 2025.